Initiation of coagulation by tissue facto

Critical Reviews in Biochemistry and Molecular Biology

Volumn 23, Issue 4, 1988, Pages 339-368

  Bach, Ronald R ^a  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

RECOMBINANT DNA; THROMBOPLASTIN;

ANIMAL; BIOSYNTHESIS; BLOOD CLOTTING; CELL CULTURE; ENZYME ACTIVATION; INFLAMMATION; KINETICS; MOLECULAR GENETICS; NEOPLASM; NUCLEOTIDE SEQUENCE; PATHOPHYSIOLOGY; PHYSIOLOGY; REVIEW; SPECIES DIFFERENCE; STRUCTURAL GENE;

ANIMAL; BASE SEQUENCE; BLOOD COAGULATION; CELLS, CULTURED; DNA, RECOMBINANT; ENZYME ACTIVATION; GENES, STRUCTURAL; INFLAMMATION; KINETICS; MOLECULAR SEQUENCE DATA; NEOPLASMS; SPECIES SPECIFICITY; THROMBOPLASTIN;

EID: 0024256963     PISSN: 10409238     EISSN: None     Source Type: Journal    
DOI: 10.3109/10409238809082548     Document Type: Article

References (190)

1. Injections de matiere cerebrale dans les reine
2. Die Chemie der Blutgerinnun
3. Purification and characterization of bovine tissue facto
4. Purification of human brain tissue facto
5. Affinity purification of human tissue factor: interaction of factor VII and tissue factor in detergent micelle
6. Isolation of cDNA clones coding for human tissue factor: primary structure of the protein and cDN
7. Molecular cloning of the cDNA for tissue factor, the cellular receptor for the initiation of the coagulation protease cascad
8. Human tissue factor: cDNA sequence and chromosome localization of the gen
9. Contribution a l'etudc de la coagulation du san
10. The nature and action of the thromboplastin (zymoplastic) substance of the tissue
11. On the evolution of clotting theor
12. Theories of blood coagulatio
13. Intermediate reactions in the coagulation of blood with tissue thromboplasti
14. The activation of factor X by extracts of rabbit brai
15. The phospholipid requirement of tissue factor in blood coagulatio
16. Characteristics and lipid requirements of coagulant proteins extracted from lung and brain: specificity of the protein component of tissue facto
17. Purification and characterization of the protein component of tissue facto
18. Binding of the protein component of tissue factor to phospholipid
19. Ultracentrifugal isolation from lung tissue of a macro-molecular protein component with tissue thromboplastic propertie
20. The thromboplastic protein: structure, properties. disintegratio
21. Studies on the mechanism of the thromboplastic effec
22. Waterfall sequence for intrinsic blood clottin
23. An enzyme cascade in the blood clotting mechanism and its function as a biological amplifie
24. Characterization of a complementary deoxyribonucleic acid coding for the a chain of human fibrinoge
25. Partial mRNA sequences for human A, Bβ, and gamma fibrinogen chains: evolutionary and functional implication
26. Characterization of complementary deoxyribonucleic acid and genomic deoxyribonucleic acid for the β chain of human fibrinoge
27. Nucleotide sequence of the gene for the gamma chain of human fibrinoge
28. Characterization of the complementary deoxyribonucleic acid and gene coding for human prothrombi
29. Cloning of a cDNA coding for human factor V, a blood coagulation factor homologous to factor VIII and ceruloplasmi
30. 'Characterization of a cDNA coding for human factor VI
31. Molecular cloning of a cDNA encoding human antihaemophilic facto
32. Characterization of the human factor VIII gen
33. Isolation and characterization of a cDNA coding for human factor I
34. Isolation and characterization of human blood-coagulation factor X cDN
35. The coagulation-kinin pathway of human plasm
36. Zymogens and cofactors of blood coagulatio
37. Initiation of coagulation and relationships between intrinsic and extrinsic coagulation pathway
38. Hereditary factor VII deficiency: heterogeneity defined by combined functional and immunochemical analysi
39. Factor VII deficienc
40. Activation of factor IX by the reaction product of tissue factor and factor VII: additional pathway for initiating blood coagulatio
41. Is hemophilia a disease of the tissue factor pathway of coagulatio
42. Activation and control of factor VII by activated factor X and thrombi
43. Isolation and characterization of bovine factor VI
44. Purification and characterization of human coagulation factor VI
45. Isolation and characterization of human factor VI
46. Zurchemischen Konstitution des Lipid der Thrombokinas
47. Studien uber Gewbethromboplastin. I. Reinigung. Chem-ische, Charakterisierung und Trennung in einen Eiweiss-und Lipoidantei
48. The activity of lung microsomes in blood coagulatio
49. The activity of human placenta microsomes and brain particles in blood coagulatio
50. Studies of tissue thromboplastin; its splitting into two separate part
51. The protein component of human brain thromboplasti
52. The interaction of the ptbtein and phospholipid components of tissue thromboplastin (factor III) with the factors VII and
53. Purification and some properties of the protein component of tissue thromboplastin from human brai
54. Binding of bovine brain tissue factor to concanavalin A-Sepharos
55. Concanavalin A inhibits tissue factor coagulant activit
56. Concanavalin A inhibition of tissue factor (thromboplastin) activit
57. The development of monospecific antibodies against human thromboplastin apoprotein (apoprotein III) and their application in the immunocytochemical detection of the antigen in blood cell
58. Factor VII binding to tissue factor in reconstituted phospholipid vesicles: induction of cooperativity by phosphatidylserin
59. Monoclonal antibodies against bovine tissue factor, which block interaction with factor VII
60. An inhibitory monoclonal against human tissue facto
61. Base sequence studies of 300 nucleotide renatured repeated human DNA clone
62. Identification of a common nucleotide sequence in the 3 '-untranslated region of mRNA molecules specifying inflammatory mediator
63. A conserved AU sequence from the 3' untranslated region of GM-CSF mRNA mediates selective mRNA degradatio
64. Covalent binding of fatty acid to the transferrin receptor in cultured human cell
65. 3H]palmitic aci
66. Two classes of fatty acid acylatcd proteins exist in eukaryotic cell
67. Studies on the attachment of myristic and palmitic acid to cell proteins in human squamous carcinoma cell lines: evidence for two pathway
68. The HLA-D-associated invariant chain binds palmitic acid at the cysteine adjacent to the membrane segmen
69. Acylation of disc membrane rhodopsin may be nonenzymati
70. A simple procedure for removing contaminating aldehydes and peroxides from aqueous solutions of polyethylene glycols and of nonionic detergents that are based on the polyoxyethylene linkag
71. Continuous chromogenic tissue factor assay: comparison to clot-based assays and sensitivity established using pure tissue facto
72. Mechanisms for the incorporation of proteins in membranes and organelle
73. Characterization of a thrombomodulin cDNA reveals structural similarity to the low density lipoprotein recepto
74. Human thrombomodulin: complete cDNA sequence and chromosome localization of the gen
75. The human LDL receptor: a cysteine-rich protein with multiple Alu sequences in its mRN
76. The J.D. mutation in familial hypercholesterolemia: amino acid substitution in the cytoplasmic domain impedes internalization of LDL recepto
77. The gene for tissue factor (coagulation factor III) is localized on human chromosome lpter-lp21. Human Gene Mapping
78. Tissue factor activity of normal and neoplastic cells: quantitation and species specificit
79. Synthesis of thromboplastin protein by a murine macrophage-like cell lin
80. Species specificity of tissue thromboplasti
81. The role of cellular cooptration in thromboplastin synthesi
82. Complete amino acid sequence of streptokinase and its homology with serine protease
83. Immunoaffinity purification of bovine factor
84. Quantitation of factor VII in the plasma of normal and warfarin-treated individuals by ra-dioimmunoassa
85. Mechanism of activation of bovine factor VI
86. Activation of bovine factor VII by Hageman factor fragment
87. Activation of human factor VII by activated factors DC and
88. Tissue factor accelerates the activation of coagulation factor VII: the role of a bifunctional coagulation cofacto
89. The dual role of factor VII in blood coagulatio
90. Coagulation factor III (tissue factor) interaction with phospholipid vesicles induced by cadmium: characterization of the reconstituted protein-membrane comple
91. Binding of human factor VII and VIIa to monocyte
92. Cooperative interaction between factor VII and cell surface-expressed tissue facto
93. An ordered addition, essential activation model of the tissue factor pathway of coagulation: evidence for a conformational cag
94. Kinetics of the activation of bovine coagulation factor X by components of the extrinsic pathwa
95. Kinetics of factor IX activation via the extrinsic pathwa
96. The role of activated factor X in the control of bovine coagulation factor VI
97. Activation of human factor VII in the initiation of tissue factor-dependent coagulatio
98. Correctio
99. Tissue factor and hemostasi
100. A correlation between surface charge and coagulant action of phospholipid
101. Membrane-dependent coagulation reaction is independent of the concentration of phospholipid-bound substrate: fluid phase factor X regulates the extrinsic syste
102. The assembly of blood clotting complexes on membrane
103. Association of tissue factor activity with the surface of cultured cell
104. Tissue-factor coagulant activity of cultured human endothelial and smooth muscle cells and fibroblast
105. Interleukin 1 (IL-1) induces biosynthesis and cell surface expression of procoagulant activity in human vascular endothelial cell
106. Cellular requirements for tissue factor generation by bovine aortic endothelial cells in cultur
107. Stimulation of leukocyte thromboplastic activity by endotoxi
108. Lipid A as the biological active moiety of bacterial endotoxin (LPS) initiated generation of procoagulant activity in peripheral blood leukocyte
109. The endotoxin-induced coagulant activity of human monocyte
110. Tissue thromboplastin activity of isolated human monocyte
111. Development of tissue factor activity in mononuclear cells cultured in vitr
112. Tissue factor in cultured cells (metabolic control
113. Tissue factor in cultured cells (phamacologic effects
114. Platelet effects on tissue factor and fibrinolytic inhibition of cultured human fibroblasts and vascular cell
115. Endotoxin enhances tissue factor and suppresses thrombomodulin expression of human vascular endothelium in vitr
116. Interleukin- 1 activation of vascular endothelium: effects on procoagulant activity and leukocyte adhesio
117. Interleukin J induces endotherlial cell procoagulant while suppressing cell-surface anticoagulant activit
118. Interleukin l stimulates endothelial cell tissue factor production and expression by a prostaglandin-independent mechanis
119. Modulation of endothelial cell hemostatic properties by tumor necrosis facto
120. Recombinant tumor necrosis factor induces procoagulant activity in cultured human vascular endothe-lium: characterization and comparison with the actions of interleukin
121. C5 chemotactic fragment induces leukocyte production of tissue factor activit
122. In vitro stimulation of tissue thromboplastin (factor III) activity in human monocytes by immune complexes and lectin
123. khromboplastin activity of mouse peritoneal macrophage
124. Antibody and immune complexes induce tissue factor production by human eadothelial cell
125. Plasma lipoprotein induction and suppression of the cellular procoagulant activity in vitro: requirements for cellular collaboratio
126. Plasma lipoprotein induction and suppression of the generation of cellular procoagulant activity in vitro: two procoagulant activities are produced by peripheral blood mononuclear cell
127. Enhancement of mononuclear procoagulant activity by platelet 12-hydroxyeicosatetracnoic aci
128. Induction of monocyte-macrophage procoagulant activity by transformed cell lie
129. Mononuclear cell tissue factor: cell of origin and requirements for activatio
130. The role of human T cells (and T cell products) for monocyte tissue factor generatio
131. Tissue factor induction in human monocytes: two distinct mechanisms displayed by different alloantigen-responsive T cell clone
132. Leukocyte procoagulant activity in man: an in vitro correlate of delayed-type hypersensitivit
133. Monocyte procoagulant inducing factor: a lympbokine involved in the T cell-instructed monocyte procoagulant response to antige
134. Comparison of procoagulant activity in tissue culture medium from normal and transformed cell
135. Comparison of procoagulant activities in extracts of normal and malignant human tissu
136. A factor X-activating cysteine protease from malignant tissu
137. Procoagulant activity associated with plasma membrane vesicles shed by cultured tumor cell
138. Amidolytic assay for procoagulant activity of lymphoid and tumor cell
139. Phospholipase C from bacillus cereus and its use in studies of tissue thmmboplasti
140. Bronchoalveolar lavage procoagulant activty in bleomycin-induced lung injury in marmosets. Characterization and reldonship to fibrin deposition and fibrosi
141. Tissue factor activity in HeLa cells measured with a continuous chromogenic assay and ELISA reade
142. In vitro generation of procoagulant activity by leukemic promyelocytes in response to cytotodc drug
143. The number of receptors for factor VII correlates with the ability of cultured cells to initiate coagulatio
144. Initiation of the extrinsic pathway of coagulatio
145. Membrane asymmetr
146. Membrane asymmetry and blood coagulatio
147. Activation of blood coagulation in Crohn's disease: increased plasma fibrinopeptide A levels and enhanced generation of monocyte tissue factor activit
148. The macrophage as an effector cel
149. Increased tissue thromboplastin activity in monocytes of patients with meningococcal infection: related to an unfavorable prognosi
150. The significance of elevated procoagulant activity in the monocytes of renal transplant recipient
151. Monocyte procoagulant activity in glomerulonephritis associated with systemic lupus erythematosu
152. Effect of immune-complex containing sera from patients with rheumatic diseases on thromboplastin activity of monocyte
153. Dipyridamole stimulates urokinase production and suppresses procoagulant activity of rabbit alveolar macrophages: a possible mechanism of antithrombotic actio
154. Thrombosis and cance
155. Tumors: wounds that do not hea
156. Inhibition of the arrest of hematogenously disseminated tumor cell
157. Fibrin as a component of the tumor stroma: origins and biological significanc
158. Role of plasma, platelets, and endothelial cells in tumor metastasi
159. Interaction of the hemostatic and immune systems in the metastatic spread of tumor cell
160. Fibrin formation: implications for tumor growth and metastasi
161. Tumor interaction with hemostasis: the rationale for the use of platelet inhibitors and anticoagulants in the treatment of cance
162. Bleeding and thrombosis in the myeloproliferative disorder
163. Activation of blood coagulation in cancer: Trousseau's syndrome revisite
164. Quantitation of fibrinogen influx and fibrin deposition and tumover in line 1 and line 10 guinea pig carcinoma
165. Inhibition of experimental blood-borne lung metastasis by protease inhibitor
166. Warfarin inhibits both procoagulant activity and metastatic capacity of Lewis lung carcinoma cells: role of vitamin K deficienc
167. Isolation and characterization of antistasin: an inhibitor of metastasis and coagulatio
168. Plasma high density lipoproteins inhibit the activation of coagulation factor X by factor Wa and tissue facto
169. Tissue factor (coagulation factor III) inhibition by apolipoprotein A-I
170. Human placental anticoagulant protein: isolation and characterizatio
171. Monoclonal immunoglobulin M(lambda) coagulation inhibitor with phospholipid specificit
172. Further studies on the modulation of blood coagulation by human serum amyloid P component and its acute phase homologue C-reactive protei
173. Falsely prolonged prothrombin time due to an inhibitor to human thromboplasti
174. Demonstration of antithromboplastic activity in normal and hemophilic plasma
175. Studies on the intravascular thromboplastic effect of tissue suspensions in mic
176. The active principle of placental toxin: thromboplastin; its inactivator in blood: anti-thromboplasti
177. Identification of a thromboplastin inhibitor in serum and in plasm
178. Inhibition of tissue factor/factor VIIa activity in plasma requires factor X and an additional plasma componen
179. Characterization of the inhibition of tissue factor in seru
180. Studies of a mechanism inhibiting the initiation of the extrinsic pathway of coagulatio
181. Isolation of the tissue factor inhibitor produced by HepG2 hepatoma cell
182. Partial purification and characterization of extrinsic pathway inhibitor (the factor Xa-dependent plasma inhibitor of factor VIIa/tissue factor
183. Inhibitor of the factor VIIa-tissue factor complex is reduced in patients with disseminated intravascular coagulation but not in patients with severe hepatocellular diseas
184. Kinetics of the tissue factor-dependent activation of coagulation factors IX and X in a bovine plasma syste
185. Tissue factor-dependent activation of tritium-labeled factor IX and factor X in human plasm
186. Molecular weight analysis of oligopeptides by electrophoresis in polyacrylamide gel with sodium dodecyl sulfat
187. A simple method for displaying the hydropathic character of a protei